Director, Chief Executive Officer · Tonix Pharmaceuticals Holding Corp. · Common Stock, $0.001 par value
Side
BUY
Value
$63K
Shares
5,000
Price
$12.62
Executed
Mar 31, 2026
Disclosed
Apr 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 31 executedApr 1, 2026 disclosed
TNXP · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lederman Seth filed this Form 4 reporting a open-market purchase of TNXP on Mar 31, 2026. It became public on Apr 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Lederman Sethcik:0001563420
Issuer
Tonix Pharmaceuticals Holding Corp.cik:0001430306
Revision history · 0
No field has changed since this record was first ingested.
